Citigroup »

C4 Therapeutics shares owned by Citigroup

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2023-12-31 $765k 136k 5.65
2023-09-30 $107k 58k 1.85
2023-03-31 $4.5k 1.4k 3.14
2022-12-31 $465k 79k 5.90
2022-09-30 $913k 104k 8.77
2021-12-31 $2.7M 83k 32.20
2021-03-31 $2.1M 58k 36.99
2020-12-31 $67k 2.0k 33.17